The evolution and impact of therapy in multiple myeloma-Reference-Cited by-同舟云学术

The evolution and impact of therapy in multiple myeloma

Published:2010-02-19 Issue:S1 Volume:27 Page:1-6
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Laubach Jacob P.,Richardson Paul G.,Anderson Kenneth C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-010-9442-2.pdf

Reference85 articles.

1. McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Couplan RW. Plasma cell neoplasms. In: Swedlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008.

2. Solly S. Remarks on the pathology of mollities ossium with cases. Med Chir Trans Lond. 1844;27:435–61.

3. Kyle RA. Multiple myeloma: an odyssey of discovery. Br J Haematol. 2000;111(4):1035–44.

4. Bence Jones H. Chemical pathology. Lancet. 1847;2:88–92.

5. Bence Jones H. On the new substance occurring in the urine of a patient with mollities ossium. Philos Trans R Soc Lond. 1848;138:55–62.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs;Cancers;2022-05-10

2. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma;Leukemia;2021-02-17

3. The Possible Role of Point Mutations and Activation of the CDC27 Gene in Progression of Multiple Myeloma;Meta Gene;2020-12

4. CUL4A as a marker and potential therapeutic target in multiple myeloma;Tumor Biology;2017-07

5. CIP2A regulates proliferation and apoptosis of multiple myeloma cells;Molecular Medicine Reports;2016-07-27